Status:
COMPLETED
ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH
Lead Sponsor:
Sanofi
Conditions:
Prostatic Hyperplasia
Acute Urinary Retention
Eligibility:
MALE
50+ years
Phase:
PHASE3
Brief Summary
To assess the efficacy of alfuzosin 10mg OD in the management of acute urinary retention associated with BPH. To assess the safety of alfuzosin in this population and health care consumption.
Detailed Description
Double-blind, placebo controlled, randomized Multicenter, Phase III study comparing 2 parallel groups (alfuzosin 10mg OD or placebo) in patients with a first episode of acute urinary retention related...
Eligibility Criteria
Inclusion
- Male aged over 50 years
- Having given his written consent
- Presenting with a first episode of painful acute urinary retention related to BPH
- With a catheterized urine volume between mL and mL at the time of retention
Exclusion
- Associated urological diseases / troubles (e.g. infection or surgery of prostate, urinary retention f neurogenic origin
- Iatrogenic causes of urinary retention
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2004
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00290030
Start Date
May 1 2001
End Date
October 1 2004
Last Update
March 12 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.